Search research articles
Contact Us
Filters
Showing results (1-10 of 41) with videos related to
Page
of 5
Sort By:
Onkologie
|
July 16, 2010
Clinical applications of adoptive natural killer cell immunotherapy for cancer: current status and future prospects
Hongfeng Guo, Xifeng Qian
Oncotargets and Therapy
|
June 18, 2015
Clinical utility and patient consideration in the use of lenalidomide for multiple myeloma in Chinese patients
Jing Wang, Hongfeng Guo, Xin Zhou
Peerj. Computer Science
|
September 12, 2022
Mitigation of block withholding attack based on zero-determinant strategy
Min Ren, Hongfeng Guo, Zhihao Wang
Physica A
|
December 26, 2022
Analysis of global stock markets' connections with emphasis on the impact of COVID-19
Hongfeng Guo, Xinyao Zhao, Hang Yu, et al.
Biochemical and Biophysical Research Communications
|
February 7, 2012
MicroRNAs regulate osteogenesis and chondrogenesis
Shiwu Dong, Bo Yang, Hongfeng Guo, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 8, 2010
Rapid fatal pulmonary complications in a Chinese patient after bortezomib treatment for ALK-negative anaplastic large-cell lymphoma
Xin Zhou, Chao Sun, Jing Wang, et al.
Journal of Biomedicine & Biotechnology
|
August 14, 2010
Upregulation of endogenous HMOX1 expression by a computer-designed artificial transcription factor
Hongfeng Guo, Yi Tian, Hai Lu, et al.
Journal of Alternative and Complementary Medicine (New York, N.Y.)
|
November 18, 2011
Varicella-zoster virus prophylaxis with the traditional Chinese medicine Radix isatidis (Banlangen) in patients with multiple myeloma treated with bortezomib
Hongfeng Guo, Jingjue Mao, Xifeng Qian, et al.
BMB Reports
|
January 27, 2011
The microRNA expression profiles of mouse mesenchymal stem cell during chondrogenic differentiation
Bo Yang, Hongfeng Guo, Yulan Zhang, et al.
Hematology (Amsterdam, Netherlands)
|
February 23, 2016
Real-world outcome and healthcare costs of relapsed or refractory multiple myeloma: A retrospective analysis from the Chinese experience
Xin Zhou, Jun Xia, Jingjue Mao, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 41) with videos related to
Sort By:
Page
of 5
Onkologie
|
July 16, 2010
Clinical applications of adoptive natural killer cell immunotherapy for cancer: current status and future prospects
Hongfeng Guo, Xifeng Qian
Oncotargets and Therapy
|
June 18, 2015
Clinical utility and patient consideration in the use of lenalidomide for multiple myeloma in Chinese patients
Jing Wang, Hongfeng Guo, Xin Zhou
Peerj. Computer Science
|
September 12, 2022
Mitigation of block withholding attack based on zero-determinant strategy
Min Ren, Hongfeng Guo, Zhihao Wang
Physica A
|
December 26, 2022
Analysis of global stock markets' connections with emphasis on the impact of COVID-19
Hongfeng Guo, Xinyao Zhao, Hang Yu, et al.
Biochemical and Biophysical Research Communications
|
February 7, 2012
MicroRNAs regulate osteogenesis and chondrogenesis
Shiwu Dong, Bo Yang, Hongfeng Guo, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 8, 2010
Rapid fatal pulmonary complications in a Chinese patient after bortezomib treatment for ALK-negative anaplastic large-cell lymphoma
Xin Zhou, Chao Sun, Jing Wang, et al.
Journal of Biomedicine & Biotechnology
|
August 14, 2010
Upregulation of endogenous HMOX1 expression by a computer-designed artificial transcription factor
Hongfeng Guo, Yi Tian, Hai Lu, et al.
Journal of Alternative and Complementary Medicine (New York, N.Y.)
|
November 18, 2011
Varicella-zoster virus prophylaxis with the traditional Chinese medicine Radix isatidis (Banlangen) in patients with multiple myeloma treated with bortezomib
Hongfeng Guo, Jingjue Mao, Xifeng Qian, et al.
BMB Reports
|
January 27, 2011
The microRNA expression profiles of mouse mesenchymal stem cell during chondrogenic differentiation
Bo Yang, Hongfeng Guo, Yulan Zhang, et al.
Hematology (Amsterdam, Netherlands)
|
February 23, 2016
Real-world outcome and healthcare costs of relapsed or refractory multiple myeloma: A retrospective analysis from the Chinese experience
Xin Zhou, Jun Xia, Jingjue Mao, et al.
Page
of 5